Skip to main content
OpenTrials
Completed

NCT Number: NCT03731455

WISE Cortical Strip for Intraoperative Neurophysiological Monitoring

The WIN Study is a prospective, interventional, multi-center, open-label premarket study designed to confirm the safety, performance and intended use of the WISE Cortical Strip (WCS) for CE certification purposes. Participants with documented diagnosis of epilepsy or brain tumor requiring intracranial surgery, who meet all eligibility criteria, will undergo IntraOperative Neurophysiological Monitoring (IONM) during a neurosurgical intervention with the WCS and a comparator device.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Klinikum der Universitat München, Munich, Germany

Loading trial locations.

About this study

The IONM is the use of electrophysiological methods to identify important neural structures in the operative field, including eloquent areas, in order to monitor their functional integrity during the neurosurgical lesion resection. The benefit of performing functional monitoring of the areas surrounding the lesion is to minimize neurological damages during surgical lesions resection and thus to avoid and/or limit significant post-operative impairments. During the therapeutic resection of brain tumors or epileptogenic lesions, the use of the IONM is associated to other intraoperative techniques (e.g. brain mapping techniques) that, together to combined efforts of a multidisciplinary team of neurosurgeons, neuroradiologists, neuropsychologists, and neurophysiologists, contribute to the definition of location, extension, and extent of functional involvement that a lesion causes in an individual participant.

The principal electrophysiological methods to perform the IONM are the recording of brain's electrical activities (Somatosensory Evoked Potentials, SEPs and ElectroCorticoGraphy, ECoG) and electrical stimulation of motor regions (to elicit Motor Evoked Potentials, MEPs) using cortical strips placed on surface of the brain.

Thus, the WCS is intended to be used intraoperatively on the brain surface, to perform brain monitoring.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Brain tumor or epilepsy that require neurosurgical intervention and exposure of the central region of the cerebral cortex including at least the hand-forearm areas in the primary motor cortex and the primary somatosensory cortex (i.e. excision of lesion, open approach)
  • Age: 18 - 75 years at the time of enrollment
  • Required intraoperative neurophysiological monitoring with subdural electrodes
  • Willingness to provide informed consent for participating in the study

Exclusion critria:

  • Significant psychiatric impairments which, in the opinion of the investigator, will interfere with the proper administration or completion of the protocol
  • Acute or untreated infections (viral, bacterial or fungal)
  • Currently on any anticoagulant medication that cannot be discontinued during the perioperative period, or patients with factor XIII deficiency or any other hematological disease
  • Current treatment with antibiotics

Treatment and study plan

WISE Cortical Strip

Device

The WISE Cortical Strip is a medical device composed by a strip and by a cable.

Primary outcomes

  1. Serious Adverse Device Effects (SADEs) of the WISE Cortical Strip.

    Time frame: For the entire duration of the surgeries and after 24 hours

  2. The Signal-to-Noise Ratio percentage (SNR%) calculated on Somatosensory Evoked Potential (SEP) signals.

    Time frame: During the surgery

Secondary outcomes

  1. Impedance values measured for the WISE Cortical Strip.

    Time frame: During the surgery

  2. Motor Evoked Potentials (MEPs).

    Time frame: During the surgery

  3. Dedicated usability questionnaire.

    Time frame: Following surgeries

Sponsors and collaborators

Lead sponsor

Wise S.r.l.

Industry

Collaborators

  • Fondazione Don Carlo Gnocchi ETS
  • Genae

Registry information

Official study title

A Prospective, Interventional, Multi-center, Open-label, Premarket Study to Evaluate Safety, Performance and Usability of the Wise Cortical Strip for Intraoperative Neurophysiological Monitoring (WIN Study)

Acronym: WIN

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Nov 6, 2018
Registry last updated
Jul 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.